En Quibim hemos tenido el privilegio de colaborar en las XVI Jornadas Técnicas de AVISA, donde nuestra compañera María Mancebo González impartió una ponencia sobre un aspecto esencial en el desarrollo de dispositivos médicos basados en IA: avanzar con rigor científico y cumplir todas las exigencias regulatorias, incluso cuando los plazos son exigentes. Solo desde esa disciplina podemos ofrecer a los radiólogos y a los hospitales herramientas precisas, fiables y seguras, como las que desarrollamos con QP‑Prostate. Gracias a AVISA por abrir espacios que impulsan una innovación responsable al servicio de la salud en la Comunitat Valenciana.
Nos enorgullece anunciar que hemos sido galardonados con el Primer Premio a la Responsabilidad Social 2025 (empresas con más de 50 empleados) otorgado por la Generalitat Valenciana. Este reconocimiento pone en valor un modelo empresarial verdaderamente centrado en las personas: el fomento de la innovación tecnológica en salud para favorecer decisiones clínicas más informadas y una experiencia más humana para el paciente, al tiempo que construimos una cultura corporativa basada en el bienestar, la igualdad y un firme compromiso social. Queremos agradecer especialmente a la Conselleria de Economía por este reconocimiento, que refuerza nuestro compromiso de seguir contribuyendo activamente al fortalecimiento y la sostenibilidad de la sanidad pública valenciana.
Ahead of the European Congress of Radiology, we had the opportunity to talk to Prof. Philippe PUECH. In this blog, he shares his perspective on: 🔹 Reducing unnecessary biopsies through smarter multiparametric MRI scans 🔹 Why structured reports are key to PI-RADS consistency 🔹 The real role of AI in prostate MRI and the barriers to its routine adoption 🔹 Why young radiologists should learn to master AI, rather than fear it A practical and forward-looking conversation about how technology and clinical expertise are transforming prostate cancer diagnosis. 👉 Read the full interview on our blog: https://bit.ly/3OAdzrX #ECR2026 #ECR26 #ProstateCancer #AIinHealthcare #MedicalInnovation
As collaborators of Prostate Cancer Research, we understand firsthand how modern imaging techniques, advanced risk stratification, and AI-based diagnostic pathways can redefine prostate cancer screening — making it more accurate, safe, and equitable. The current debate on screening must reflect today's medicine. Decisions that will determine outcomes in the coming years cannot be based on outdated data. They must be based on robust, contemporary evidence and be in line with current clinical practice. Support the call for a fair and modern reassessment of prostate cancer screening in the UK: https://lnkd.in/ecSfYUQA #ProstateCancer #AIinHealthcare #MedicalInnovation
Looking forward to UroNext 2026, taking place 6–7 March in Lisbon at the Hospital CUF Tejo Auditorium, co-organised with David Subira (Coordinator of the Urology Department at CUF - Hospitais e Clínicas) and Bernardino Miñana López, MD PhD (Head of Urology at Clínica Universidad de Navarra). The meeting will bring together experts exploring innovation and AI in uro-oncology. Don’t miss Javier Pizcueta Pastor’s session on AI algorithms for treatment-zone segmentation and post-therapeutic focal assessment — 6 March, 14:30. #UroNext2026 #AIinHealthcare #MedicalInnovation
“𝘛𝘩𝘦 𝘥𝘪𝘨𝘪𝘵𝘢𝘭 𝘵𝘸𝘪𝘯 𝘳𝘦𝘱𝘳𝘦𝘴𝘦𝘯𝘵𝘴 𝘢 𝘴𝘵𝘳𝘢𝘵𝘦𝘨𝘪𝘤 𝘴𝘵𝘦𝘱 𝘵𝘰𝘸𝘢𝘳𝘥 𝘢 𝘮𝘰𝘳𝘦 𝘱𝘳𝘦𝘷𝘦𝘯𝘵𝘪𝘷𝘦 𝘢𝘯𝘥 𝘦𝘧𝘧𝘪𝘤𝘪𝘦𝘯𝘵 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘮𝘰𝘥𝘦𝘭.” This statement was shared by Ana Jimenez Pastor, VP of Science at Quibim, during her talk at the Longevity World Forum, an event that Quibim has had the pleasure of sponsoring in Madrid. During the event, we showcased how AI-powered solutions transform imaging data into actionable insights that support precision medicine and drive innovation toward healthier aging. #ArtificialIntelligence #MedicalImaging #HealthcareInnovation
La presidenta de la Comunidad de Madrid ha destacado como el Hospital Ramón y Cajal está usando tecnología de IA para la detección temprana del cáncer de próstata. Nos alegra especialmente porque detrás de esa innovación está Quibim. Que una solución nacida de la investigación privada llegue a la sanidad pública es, precisamente, lo que da sentido a nuestro trabajo. Seguimos avanzando para que la IA diagnóstica sea una herramienta accesible y transformadora en todo el sistema de salud. #CancerProstata #InnovaciónEnSalud #IAEnMedicina
In this interview, Dr. Jeronimo Barrera Ortega highlights one of radiology’s key challenges: prostate cancer. With the prevalence rates increasing, the real task isn’t just detection—it’s identifying which lesions are clinically significant and may impact patient outcomes. Here, AI and radiomics play a vital role, uncovering imaging patterns invisible to the human eye and improving diagnostic consistency. #ArtificialIntelligence #ProstateCancer #MedicalImaging #HealthcareInnovation
We are expanding our on-premise infrastructure with the integration of a new NVIDIA DGX, a system designed to accelerate how we build and scale medical AI. With this new system, our team will develop and train new artificial intelligence solutions faster, while advancing in the development of new technologies such as foundation models and generative AI — ultimately helping us deliver more precise, scalable, and impactful tools for clinicians and the patients they care for. #NVIDIADGX #MedicalAI #TechForGood
The wait is almost over: #ECR2026 is just around the corner, the countdown to Europe’s largest congress in radiology and imaging has officially begun! 📍 You’ll find our team at the Austria Center Vienna, booth AI-34, within the X1 – AI Expo zone. Ready to discover the full potential of radiomics? Let’s connect — book a meeting here https://bit.ly/3ZsHpkl #ECR26 #ECR #Radiology #MedicalImaging
